FICHA TECNICA REVOLADE 50 MG COMPRIMIDOS

revolade   Dan revolade

Revolade Active substance Eltrombopag Holder Novartis Status Closed Indication patients aged 1 year and above with primary immune thrombocytopenia

Revolade pCPA File Number: 20760 Negotiation Status: Negotiations were not pursued Indication: Thrombocytopenia associated Revolade 50 Tablet is used to prevent or lower the risk of bleeding in patients with chronic immune thrombocytopenic purpura

sun sky lottery result Revolade is available by prescription only Date filed: Contact: Bureau of Metabolism Revolade Active substance Eltrombopag Holder Novartis Status Closed Indication patients aged 1 year and above with primary immune thrombocytopenia